5:52 PM
 | 
Jan 07, 2010
 |  BC Extra  |  Company News

Kyowa gains Asian rights to Reata's bardoxolone

Reata Pharmaceuticals Inc. (Irving, Texas) granted Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) exclusive rights in Japan, China, Taiwan, Korea and Southeast Asia to...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >